O	0	12	Cooccurrence	Cooccurrence	NN	B-NP
O	13	15	of	of	IN	B-PP
O	16	23	reduced	reduce	VBN	B-NP
O	24	34	expression	expression	NN	I-NP
O	35	37	of	of	IN	B-PP
O	38	43	alpha	alpha	SYM	B-NP
O	43	44	-	-	HYPH	B-NP
O	44	51	catenin	catenin	NN	I-NP
O	52	55	and	and	CC	I-NP
O	56	70	overexpression	overexpression	NN	I-NP
O	71	73	of	of	IN	B-PP
O	74	77	p53	p53	NN	B-NP
O	78	80	is	be	VBZ	B-VP
O	81	82	a	a	DT	B-NP
O	83	92	predictor	predictor	NN	I-NP
O	93	95	of	of	IN	B-PP
B-Multi-tissue_structure	96	101	lymph	lymph	NN	B-NP
I-Multi-tissue_structure	102	106	node	node	NN	I-NP
O	107	117	metastasis	metastasis	NN	I-NP
O	118	120	in	in	IN	B-PP
O	121	126	early	early	JJ	B-NP
B-Cancer	127	134	gastric	gastric	JJ	I-NP
I-Cancer	135	141	cancer	cancer	NN	I-NP
O	141	142	.	.	.	O

O	144	154	BACKGROUND	BACKGROUND	NN	B-NP
O	155	158	AND	AND	CC	I-NP
O	159	169	OBJECTIVES	OBJECTIVES	NNS	I-NP
O	169	170	:	:	:	O
O	171	175	Even	Even	RB	B-SBAR
O	176	182	though	though	IN	I-SBAR
O	183	186	the	the	DT	B-NP
O	187	199	pathological	pathological	JJ	I-NP
O	200	210	background	background	NN	I-NP
O	211	222	contributes	contribute	VBZ	B-VP
O	223	225	to	to	TO	B-PP
B-Multi-tissue_structure	226	231	lymph	lymph	NN	B-NP
I-Multi-tissue_structure	232	236	node	node	NN	I-NP
O	237	247	metastasis	metastasis	NN	I-NP
O	247	248	,	,	,	O
O	249	252	the	the	DT	B-NP
O	253	263	biological	biological	JJ	I-NP
O	264	279	characteristics	characteristic	NNS	I-NP
O	280	282	of	of	IN	B-PP
B-Cancer	283	289	tumors	tumor	NNS	B-NP
O	290	294	have	have	VBP	B-VP
O	295	299	also	also	RB	I-VP
O	300	306	gained	gain	VBN	I-VP
O	307	311	wide	wide	JJ	B-NP
O	312	321	attention	attention	NN	I-NP
O	321	322	.	.	.	O

O	323	325	In	In	IN	B-PP
O	326	330	this	this	DT	B-NP
O	331	336	study	study	NN	I-NP
O	336	337	,	,	,	O
O	338	341	the	the	DT	B-NP
O	342	352	expression	expression	NN	I-NP
O	353	355	of	of	IN	B-PP
O	356	359	the	the	DT	B-NP
O	360	368	cadherin	cadherin	NN	I-NP
O	368	369	-	-	HYPH	B-NP
O	369	376	catenin	catenin	NN	I-NP
O	377	384	complex	complex	NN	I-NP
O	385	388	and	and	CC	I-NP
O	389	392	p53	p53	NN	I-NP
O	393	396	was	be	VBD	B-VP
O	397	404	studied	study	VBN	I-VP
O	405	407	in	in	IN	B-PP
O	408	413	early	early	JJ	B-NP
B-Cancer	414	421	gastric	gastric	JJ	I-NP
I-Cancer	422	428	cancer	cancer	NN	I-NP
O	428	429	.	.	.	O

O	430	435	Their	Their	PRP$	B-NP
O	436	447	correlation	correlation	NN	I-NP
O	448	452	with	with	IN	B-PP
B-Multi-tissue_structure	453	458	lymph	lymph	NN	B-NP
I-Multi-tissue_structure	459	463	node	node	NN	I-NP
O	464	474	metastasis	metastasis	NN	I-NP
O	475	478	and	and	CC	O
O	479	482	the	the	DT	B-NP
O	483	497	predictability	predictability	NN	I-NP
O	498	500	of	of	IN	B-PP
B-Cancer	501	506	lymph	lymph	NN	B-NP
I-Cancer	507	511	node	node	NN	I-NP
I-Cancer	512	522	metastases	metastasis	NNS	I-NP
O	522	523	,	,	,	O
O	524	526	by	by	IN	B-PP
O	527	536	combining	combine	VBG	B-VP
O	537	542	these	these	DT	B-NP
O	543	550	factors	factor	NNS	I-NP
O	550	551	,	,	,	O
O	552	556	were	be	VBD	B-VP
O	557	561	also	also	RB	I-VP
O	562	571	discussed	discuss	VBN	I-VP
O	571	572	.	.	.	O

O	573	580	METHODS	METHODS	NNS	B-NP
O	580	581	:	:	:	O
O	582	585	One	One	CD	B-NP
O	586	593	hundred	hundred	CD	I-NP
O	594	597	and	and	CC	O
O	598	601	one	one	CD	B-NP
B-Cancer	602	611	specimens	specimen	NNS	I-NP
O	612	620	obtained	obtain	VBN	B-VP
O	621	625	from	from	IN	B-PP
O	626	633	surgery	surgery	NN	B-NP
O	634	638	were	be	VBD	B-VP
O	639	646	studied	study	VBN	I-VP
O	647	649	by	by	IN	B-PP
O	650	670	immunohistochemistry	immunohistochemistry	NN	B-NP
O	671	676	using	use	VBG	B-VP
O	677	687	monoclonal	monoclonal	JJ	B-NP
O	688	692	anti	anti	AFX	I-NP
O	692	693	-	-	HYPH	I-NP
O	693	694	E	E	NN	I-NP
O	694	695	-	-	HYPH	I-NP
O	695	703	cadherin	cadherin	NN	I-NP
O	703	704	,	,	,	O
O	705	709	anti	anti	AFX	O
O	709	710	-	-	HYPH	O
O	710	715	alpha	alpha	SYM	O
O	715	716	-	-	HYPH	O
O	716	723	catenin	catenin	NN	B-NP
O	724	727	and	and	CC	O
O	728	732	anti	anti	AFX	B-NP
O	732	733	-	-	HYPH	I-NP
O	733	736	p53	p53	NN	I-NP
O	737	747	antibodies	antibody	NNS	I-NP
O	747	748	.	.	.	O

O	749	756	RESULTS	RESULTS	NNS	B-NP
O	756	757	:	:	:	O
O	758	768	Expression	Expression	NN	B-NP
O	769	771	of	of	IN	B-PP
O	772	773	E	E	NN	B-NP
O	773	774	-	-	HYPH	B-NP
O	774	782	cadherin	cadherin	NN	I-NP
O	783	786	and	and	CC	O
O	787	792	alpha	alpha	SYM	O
O	792	793	-	-	HYPH	O
O	793	800	catenin	catenin	NN	B-NP
O	801	804	was	be	VBD	B-VP
O	805	812	reduced	reduce	VBN	I-VP
O	813	815	in	in	IN	B-PP
O	816	818	50	50	CD	B-NP
O	818	819	.	.	.	O
O	819	820	5	5	CD	B-NP
O	821	824	and	and	CC	I-NP
O	825	827	64	64	CD	I-NP
O	827	828	.	.	.	O
O	828	829	4	4	CD	B-NP
O	829	830	%	%	NN	I-NP
O	830	831	,	,	,	O
O	832	844	respectively	respectively	RB	B-ADVP
O	844	845	.	.	.	O

O	846	849	p53	p53	NN	B-NP
O	850	857	protein	protein	NN	I-NP
O	858	866	staining	staining	NN	I-NP
O	867	870	was	be	VBD	B-VP
O	871	879	positive	positive	JJ	B-ADJP
O	880	882	in	in	IN	B-PP
O	883	885	29	29	CD	B-NP
O	885	886	.	.	.	O
O	886	887	7	7	CD	B-NP
O	887	888	%	%	NN	I-NP
O	888	889	.	.	.	O

O	890	895	There	There	EX	B-NP
O	896	899	was	be	VBD	B-VP
O	900	901	a	a	DT	B-NP
O	902	913	significant	significant	JJ	I-NP
O	914	925	correlation	correlation	NN	I-NP
O	926	933	between	between	IN	B-PP
O	934	935	E	E	NN	B-NP
O	935	936	-	-	HYPH	I-NP
O	936	944	cadherin	cadherin	NN	I-NP
O	945	948	and	and	CC	O
O	949	954	alpha	alpha	SYM	O
O	954	955	-	-	HYPH	O
O	955	962	catenin	catenin	NN	B-NP
O	963	973	expression	expression	NN	I-NP
O	973	974	,	,	,	O
O	975	978	but	but	CC	O
O	979	981	no	no	DT	B-NP
O	982	993	correlation	correlation	NN	I-NP
O	994	997	was	be	VBD	B-VP
O	998	1003	found	find	VBN	I-VP
O	1004	1011	between	between	IN	B-PP
O	1012	1015	p53	p53	NN	B-NP
O	1016	1026	expression	expression	NN	I-NP
O	1027	1030	and	and	CC	O
O	1031	1032	E	E	NN	B-NP
O	1032	1033	-	-	HYPH	O
O	1033	1041	cadherin	cadherin	NN	B-NP
O	1042	1044	or	or	CC	O
O	1045	1050	alpha	alpha	SYM	O
O	1050	1051	-	-	HYPH	O
O	1051	1058	catenin	catenin	NN	B-NP
O	1059	1069	expression	expression	NN	I-NP
O	1069	1070	.	.	.	O

O	1071	1072	A	A	DT	B-NP
O	1073	1082	reduction	reduction	NN	I-NP
O	1083	1085	in	in	IN	B-PP
O	1086	1091	alpha	alpha	SYM	B-NP
O	1091	1092	-	-	HYPH	B-NP
O	1092	1099	catenin	catenin	NN	I-NP
O	1100	1110	expression	expression	NN	I-NP
O	1111	1114	and	and	CC	O
O	1115	1118	p53	p53	NN	B-NP
O	1119	1133	overexpression	overexpression	NN	I-NP
O	1134	1144	correlated	correlate	VBD	B-VP
O	1145	1147	to	to	TO	B-PP
B-Cancer	1148	1153	lymph	lymph	NN	B-NP
I-Cancer	1154	1158	node	node	NN	I-NP
I-Cancer	1159	1169	metastases	metastasis	NNS	I-NP
O	1169	1170	,	,	,	O
O	1171	1183	respectively	respectively	RB	B-ADVP
O	1183	1184	.	.	.	O

O	1185	1197	Multivariate	Multivariate	JJ	B-NP
O	1198	1206	analysis	analysis	NN	I-NP
O	1207	1213	showed	show	VBD	B-VP
O	1214	1218	that	that	IN	B-SBAR
O	1219	1231	cooccurrence	cooccurrence	NN	B-NP
O	1232	1234	of	of	IN	B-PP
O	1235	1242	reduced	reduce	VBN	B-NP
O	1243	1253	expression	expression	NN	I-NP
O	1254	1256	of	of	IN	B-PP
O	1257	1262	alpha	alpha	SYM	B-NP
O	1262	1263	-	-	HYPH	B-NP
O	1263	1270	catenin	catenin	NN	I-NP
O	1271	1274	and	and	CC	I-NP
O	1275	1289	overexpression	overexpression	NN	I-NP
O	1290	1292	of	of	IN	B-PP
O	1293	1296	p53	p53	NN	B-NP
O	1297	1300	was	be	VBD	B-VP
O	1301	1303	an	an	DT	B-NP
O	1304	1315	independent	independent	JJ	I-NP
O	1316	1322	factor	factor	NN	I-NP
O	1323	1333	indicating	indicate	VBG	B-VP
B-Cancer	1334	1339	lymph	lymph	NN	B-NP
I-Cancer	1340	1344	node	node	NN	I-NP
I-Cancer	1345	1355	metastases	metastasis	NNS	I-NP
O	1355	1356	.	.	.	O

O	1357	1367	CONCLUSION	CONCLUSION	NN	B-NP
O	1367	1368	:	:	:	O
O	1369	1370	A	A	DT	B-NP
O	1371	1376	study	study	NN	I-NP
O	1377	1379	of	of	IN	B-PP
O	1380	1384	both	both	CC	O
O	1385	1390	alpha	alpha	SYM	B-NP
O	1390	1391	-	-	HYPH	B-NP
O	1391	1398	catenin	catenin	NN	I-NP
O	1399	1402	and	and	CC	I-NP
O	1403	1406	p53	p53	NN	I-NP
O	1407	1417	expression	expression	NN	I-NP
O	1418	1421	may	may	MD	B-VP
O	1422	1424	be	be	VB	I-VP
O	1425	1432	helpful	helpful	JJ	B-ADJP
O	1433	1435	to	to	TO	B-VP
O	1436	1443	predict	predict	VB	I-VP
B-Cancer	1444	1449	lymph	lymph	NN	B-NP
I-Cancer	1450	1454	node	node	NN	I-NP
I-Cancer	1455	1465	metastases	metastasis	NNS	I-NP
O	1466	1468	in	in	IN	B-PP
O	1469	1474	early	early	JJ	B-NP
B-Cancer	1475	1482	gastric	gastric	JJ	I-NP
I-Cancer	1483	1489	cancer	cancer	NN	I-NP
O	1489	1490	.	.	.	O

